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Chikungunya virus (CHIKV) emerged in Indian Ocean
islands in 2005 and is causing an ongoing outbreak that
involves >260,000 patients, including travelers returning
home from these islands. We investigated cases in 4
patients returning from Mayotte and Reunion Islands with
CHIKV infection and a nurse infected in metropolitan
France after direct contact with the blood of a traveler. Four
patients had tenosynovitis and pain at wrist pressure, and 1
had life-threatening manifestations. Four CHIKV strains
were isolated, including 1 from the patient with the
autochthonous case. The complete genomic sequence
identified a new CHIKV variant emerging from the East/
central African evolutionary lineage. Aedes albopictus, the
implicated vector of CHIKV in Indian Ocean islands, has
dispersed worldwide in recent decades. High viral loads in
patients returning from Indian Ocean islands to countries
where  Ae. albopictus is prevalent may be a source of
epidemics.
H
uman pandemics and emerging infectious diseases
such as influenza, HIV, dengue hemorrhagic fever,
West Nile encephalitis, and possibly severe acute respira-
tory syndrome have been attributed to the ability of RNA
viruses to evolve rapidly and expand their vector or host
range (1). To date, most Western countries have escaped
much of the health problems that RNA arboviruses inflict
on humans in the tropics. However, recent events suggest
that this situation may be changing (2). The emergence of
West Nile virus in 1999 in the United States and its subse-
quent rapid spread demonstrated that arboviruses are still a
threat, even in temperate, industrialized countries. West
Nile fever has become the dominant vectorborne viral dis-
ease in the United States, with >20,000 reported human
cases, 770 deaths, and an estimated 215,000 illnesses dur-
ing the past 7 years (3).
A recent outbreak of chikungunya fever in the islands
of the Indian Ocean has drawn attention to chikungunya
virus (CHIKV, genus Alphavirus, family Togaviridae) (4),
first identified in the 1950s in Africa. There, it is main-
tained in a sylvatic cycle involving wild primates and for-
est-dwelling  Aedes mosquitoes that resembles the
epidemiologic cycle of yellow fever virus (5–7). CHIKV
has since been associated with the urban Aedes aegypti
mosquito (possibly supplemented by Ae. albopictus) in
Asian countries in an epidemiologic cycle resembling that
of dengue and characterized by the absence of an animal
reservoir, direct human-to-human transmission by urban
mosquitoes, and the potential for major epidemics (8–11).
At the beginning of 2005, an outbreak of chikungunya
fever was observed in the southeastern islands of the
Indian Ocean. The epidemic was most noticeable in urban
and semiurban areas of the Comoros Islands, where
>5,000 cases have been reported. Thereafter the virus has
circulated in other islands, including Reunion and Mayotte
(2 French territories), Mauritius, the Seychelles, and
Madagascar (12–15). The population of these islands is
>22 million (16). At the beginning of 2006, Reunion was
experiencing an explosive outbreak. On June 1, an estimat-
ed 264,000 CHIKV infections (in a population of 770,000)
were reported; 237 death certificates mentioned CHIKV as
the possible cause of death (17). The implicated vector in
this outbreak is Ae. albopictus, the Asian tiger mosquito
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France(12,17). This mosquito was originally indigenous to
Southeast Asia, the Western Pacific, and the Indian Ocean
but has recently spread to Africa, the Middle East, Europe
and the Americas, mainly because of transportation of dor-
mant eggs in tires (10). 
The Indian Ocean islands are popular tourist destina-
tions. According to the World Organisation of Tourism, in
2002, some 719,000 tourists arrived in Mauritius, 432,000
in Reunion, 139,000 in Madagascar, and 122,000 in the
Seychelles (18). In 2004, an estimated 1,474,218 persons
traveled from Madagascar (153,766), Mauritius (657,312),
Mayotte (63,372) Reunion (498,388), and Seychelles
(101,380) to the European mainland (19). In addition, hun-
dreds of cases of CHIKV infections have been reported in
India and Malaysia (19). Recently, CHIKV-infected travel-
ers returned home to countries where competent vectors
are indigenous (19), which raises serious concern for
potential disease spread. We describe 4 patients who
returned to southern France, where the Asian tiger mosqui-
to has been established since 2005, with CHIKV infection.
One of them was the source of an autochthonous nosoco-
mial infection in a nurse in metropolitan France. 
Patients
Patient 1, a 73-year-old man, returned from Reunion on
February 17, 2006. His medical history included type 2
diabetes mellitus and oral treatment with imatinib for an
intestinal stromal tumor with liver metastasis that was sur-
gically removed in 2004. He was admitted for a 3-day his-
tory of fever (temperature 38.5°C) and arthralgia. Clinical
signs included asthenia, anorexia, nausea, myalgia,
headache, bilateral conjunctivitis, and arthralgia that was
particularly intense in shoulders and elbows, left ankle,
and left wrists, which suggested tenosynovitis. Purpuric
lesions of the legs and intense pain in response to pressure
on the left wrist were noticed. Laboratory findings showed
severe pancytopenia, including reduced platelet count
(17×109 cells/L), reduced leukocyte count (0.7×109
cells/L), and nonregenerative anemia (hemoglobin 9.5
g/dL, 10×109 reticulocytes/L) (Figure 1). Blood chemistry
values included raised enzymes: 1,858 IU/L lactate dehy-
drogenase (LDH), 283 IU/L aspartate aminotransferase
(AST), 210 IU/L alanine aminotransferase (ALT), 672
IU/L creatine phosphokinase, and 84 IU/L γ-glutamyl
transaminase. Bone marrow smear was cell-rich; granulo-
cytic cells were predominant and hemophagocytosis was
limited. Escherichia coli septicemia occurred during the
neutropenic period and was successfully treated with cef-
triaxone. The patient recovered slowly after a 5-day regi-
men of high-dose intravenous immunoglobulin, but
intensive joint pain persisted. On March 2, bone scintigra-
phy showed diffuse inflammation of all joints, specifically
at the left shoulder, wrist, and hand (Figure 2A). 
Patient 2 was a 5-month-old Canadian child who was
hospitalized in Marseilles on February 24, 3 days after
returning from Reunion and a few days before traveling to
Canada. Symptoms included fever and a macular rash; lab-
oratory findings showed elevated serum C-reactive protein
(CRP) (37 mg/L) and AST (59 IU/L). Blood cell counts
showed no abnormalities. He was discharged, and his fever
slowly abated.
Patient 3 was a 31-year-old woman who had been liv-
ing in Marseilles since 1987 and who had returned from
Mayotte, a French Comoros island, on February 28, 2006.
Two days later, she was admitted with fever (temperature
39.2°C), nausea, myalgia, lumbar pain, headache, bilateral
conjunctivitis (Figure 2B), and severe bilateral arthralgia
(shoulders, knees, and particularly ankles, elbows, wrists,
and fingers). Exquisite pain was noted when pressure was
applied to the right wrist. Laboratory findings included
negative blood smears for malaria, anemia (hemoglobin
10.8 g/dL), and lymphopenia (0.6×109 cells/L). Blood
chemistry values were within normal limits, except for
raised enzymes (177 IU/L AST, 116 IU/L ALT, 780 IU/L
LDH), hypocholesterolemia (3.5 mmol/L), and CRP (64
mg/L). Fever disappeared at day 4, and the patient was dis-
charged, although still in pain.
In January 2006, a 75-year-old female patient (patient
4) returned from Reunion with a sudden-onset fever, asthe-
nia, arthralgia with wrist pain, and diarrhea. Two days
later, blood specimens were collected at the patient’s home
by a 60-year-old female nurse (patient 5). At this time,
patient 4 had high fever (temperature 40°C). Three days
later, fever, skin rash, and arthralgia with pain at wrist
pressure developed in the nurse. Interview and examina-
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Figure 1. Evolution of viral load and blood cell counts in a 73-year-
old man who had returned from Reunion during the acute phase
of chikungunya virus (CHIKV) infection. PMN, polymorphonuclear
leukocytes.tion did not show recent travel abroad, mosquito bite, acci-
dental skin puncture during blood sampling, skin lesion, or
eczema. The nurse washed her hands with a hydroalco-
holic solution before and after drawing blood, but she did
not wear gloves. She noted direct contact with patient 4’s
blood during hemostasis.
Methods
Acute-phase sera obtained from patients 1, 2, 3, and 5
were tested for CHIKV RNA through a quantitative real-
time reverse transcription (RT)-PCR test (20) and used for
partial E1 gene sequence determination and virus isolation
in Vero E6 cells. Viral loads were estimated by compara-
tive analysis by using threshold values obtained with seri-
al dilutions of a 450-nucleotide (nt) in vitro transcribed
RNA, quantified spectrophotometrically as previously
reported (21), encompassing the target region (detailed
protocol available on request). CHIKV-specific
immunoglobulin G (IgG) and IgM were tested in acute-
and convalescent-phase sera by an indirect fluorescent
antibody test with a hyperimmune mouse ascitic fluid pre-
pared against CHIKV Ross strain in conjunction with a
fluorescein isothiocyanate–conjugated goat anti-human
IgG (Fluoline G, bioMérieux, Marcy l’Etoile, France) as
previously described (22). Primers used to completely
sequence strain LR2006-OPY1 (first passage) were
designed from CHIKV and o’nyong-nyong virus
sequences retrieved from GenBank. Sequence reconstruc-
tion was performed with Sequencer software program
(Gene Codes Corp., Ann Arbor, MI, USA). E1 gene
sequences (1,225 nt) were generated by using primers
CHIKE1S1, 7 ACATCACGTGCGAGTACAAAAC and
CHIKE1R1, TCTCTTAAGGGRCACATATACC. Phylo-
genetic and evolution studies were performed with E1
sequences as previously described (23) with ClustalX ver-
sion 1.81 (24) for sequence alignments and MEGAversion
2.1 (25) for phylogenetic analyses. 
Results
CHIKV infection was diagnosed by positive RT-PCR in
acute-phase sera (viral loads of 3.3×109, 1.0×107, 4.2×108,
and 2.0×108 copies/mL in patients 1, 2, 3, and 5, respec-
tively). Patient 1’s viral load decreased to 2×104 copies/mL
at day 2 and 3 and was negative at day 4 (Figure 1). Patient
3’s viral load decreased to 7×105 copies/mLat day 4, 3×104
copies/mL at day 7, and was negative at day 8. Infection
was also diagnosed by seroconversion with no antibody in
acute-phase serum and IgM and IgG in convalescent-phase
serum or isolated IgM in acute-phase serum (patient 2, no
convalescent-phase serum) and by virus isolation from
acute-phase serum (isolates LR2006-OPY1, LR2006-
OPY2, MCF2006-OPY4, and GARD2006-OPY6 for
patients 1, 2, 3, and 5, respectively). 
A 1,044-nt sequence of the E1 gene was used for com-
parative genetic analysis of sequences from Indian Ocean
CHIKV and reference strains from diverse geographic and
temporal origins (23). Indian Ocean strains formed a sub-
lineage that is closely related to but distinct from viruses
belonging to the East/Central African evolutionary lineage
(Figure 3). The E1 nucleotide sequences of the 4 CHIKV
isolates from 2006 (GenBank accession nos.
DQ451149–DQ451151) were 100% identical, while
ranges of 2.1%–3.3%, 14.8%–15.8%, and 5.5%–6.4% of
nucleotide divergence were observed when compared with
isolates from Central/East Africa, West Africa, and Asia,
respectively.
Phylogenetic analysis and high bootstrap values indicat-
ed that the 4 Indian Ocean strains had a common ancestor,
constituted a new sublineage that is distinct from the 4 lin-
eages previously recognized, and most likely emerged
recently to cause the regional outbreak (26). Two muta-
tions, which are apparently specific for strains circulating in
Reunion and Mayotte, consist of A1028→V and D1086→E
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Figure 2. Clinical findings in patients. A) Bone scintigraphy of the
wrists and hands showing an intense focus of technetium-
99m–labeled methylene diphosphonate tracer uptake, particularly
on the left side in the left metacarpophalangeal, wrist, and the first
distal interphalangeal joints in a 73-year-old man who returned
from Reunion with a severe viremic chikungunya virus (CHIKV)
infection. B) Conjunctivitis in a 31-year-old woman who returned
from Mayotte, French Comoros, with a severe viremic CHIKV
infection.substitutions with reference to all other CHIKV strains
characterized to date, regardless of evolutionary lineage
(amino acid positions refer to the sequence of the original
Ross isolate, accession no. AF490259). A and D residues
are also found in available sequences of o’nyong-nyong
virus, another alphavirus distantly related to CHIKV. The
complete coding sequence of the strain recovered from
patient 1 (LR2006 OPY1) was determined and deposited in
GenBank (accession no. DQ443544). Comparative analysis
with the 3 other full-length sequences available for CHIKV
showed that the overall nucleotide distances were 2.7%
(1.4% amino acid) with East/Central strains and 14.8%
(4.4% amino acid) with West African strains (no full-length
sequence was available for CHIKV strains from Asia).
Diagnosis of a CHIKV infection in patient 5 was based
on clinical (typical chikungunya fever signs and symp-
toms), epidemiologic (taking care of a patient who was
returning from Reunion at the time of the outbreak), and
serologic (IgM- to IgG-specific conversion) evidence.
After contact with patient 4, CHIKV infection of patient 5
was shown by RT-PCR, virus isolation, and seroconver-
sion as reported above.
Discussion
Visitors to tropical countries and workers migrating to
Western countries may serve as sentinels for the global dis-
semination and emergence of viral, bacterial, and parasitic
agents that affect local populations in the tropics (27). As
an example, the outbreak of chikungunya fever in 2005 in
the Comoros Islands led to the first documented CHIKV
infections imported into France by travelers who had visit-
ed the islands (28). The patients reported here had typical
clinical signs and symptoms of CHIKV infection, includ-
ing febrile polyarthritis with papular, macular, or purpuric
rashes; hemorrhagic manifestations are, however, uncom-
mon. Another characteristic was severe arthralgia accom-
panied by extremely painful arthritis and tenosynovitis and
specific pain when pressure was applied to the wrists.
Severe thrombocytopenia and neutropenia complicated by
septicemia developed in patient 1. In Reunion, complicat-
ed clinical syndromes have been reported mainly in new-
borns, the elderly, and disabled patients (17). Previous
studies have shown that a proportion of CHIKV-infected
patients remain in severe pain for months (29,30). In
patient 1, and in subsequent patients in our units, we also
observed late-to-chronic CHIKV rheumatic manifesta-
tions, particularly subacute tenosynovitis of the wrists,
hands, and ankles (31). 
Virologic studies identified a new CHIKV variant in
patients infected from Mayotte and Reunion, with specific
amino acid mutations in the E1 gene; these findings may be
useful in the future for tracing dissemination of the virus.
The genetic heterogeneity between this variant and other
strains in the East/Central Africa lineage has a magnitude
equivalent to or higher than that observed between strains
of West Nile virus circulating in southern Europe and the
Middle East for the past 4 decades and which emerged and
dispersed in the United States in 1999. Phylogenetic analy-
sis showed that this variant originated from the
East/Central African lineage of CHIKV and emerged
recently, in accordance with the observed epidemic pattern.
High viremia was observed in this study (up to 3.3×109
copies/mL), which enabled virus isolation from all viremic
patients. We used the same diagnostic system as reported
by Pastorino et al. (20), but viral load was quantified with
RNAthat encompassed the target region by using a method
similar to that described previously (21). RNA was then
quantified by spectrophotometry, diluted serially from 100
to 10–14; the 4 highest dilutions that provided a positive
result were included in each diagnostic experiment. The
quantification was performed with an in vitro–transcribed
RNA based on a strain that was genetically distinct from
those circulating in Indian Ocean islands. However, in the
region targeted by the real-time PCR assay, 206 of 209 sites
are conserved between the sequence of Ross strain and
strains circulating in 2006 in the Indian Ocean region.
Moreover, no mismatch exists in the sequence targeted by
the primers or the probe. This finding suggests that the
quantification of viral loads, although approximate, is a
good reflection of biologic reality.
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Figure 3. Phylogenetic analysis of chikungunya virus (CHIKV) iso-
lates based on a 1,044-nucleotide (nt) fragment between nt 10243
and 11286 (numbered after strain Ross [accession no. AF490259])
in the E1 gene. Distances and groupings between the 3 Indian
Ocean isolates and 18 isolates previously characterized (23) were
determined by the Jukes-Cantor algorithm and neighbor-joining
method with the MEGA software program (25). Bootstrap values
>75% are indicated and correspond to 500 replications. The main
evolutionary lineages, East/Central African (brown), eastern/
southern Africa (red), West African (blue), and Asian (yellow), are
indicated. The Indian Ocean sublineage is indicated in orange.
Boldface indicates sequence determined in this study.Although viral loads up to 109 have been reported in
dengue virus infection, such levels of viremia are uncom-
mon in arthropodborne viral diseases such as dengue fever
and West Nile virus infection (32–34). In the absence of
published data, we cannot determine whether high viral
loads are common during CHIKV infection or specific to
Indian Ocean strains. They may account for the autochtho-
nous case reported here. Patient 5’s CHIKV infection was
associated with direct contact with the blood of patient 4;
in addition, Aedes spp. do not generally bite in southern
France during the winter. Virus transmission through direct
contact with highly viremic blood appears to be the most
plausible hypothesis to explain this autochtonous CHIKV
infection. Whether the skin was intact when contact with
infected blood occurred could not be clearly determined.
A major determinant of outbreak dynamics is the eco-
logic cycle of the virus and its vector. This cycle in
Reunion probably follows a denguelike model character-
ized by the absence of an animal reservoir and the ability
to spread rapidly among humans through peridomestic
mosquito bites. We suspect that direct transmission to
healthcare workers may have also occurred in disease-
endemic countries, but it was not identified.
Because dengue virus does not require a nonhuman ver-
tebrate reservoir, it was able to disseminate in regions
where competent vectors were present. CHIKV may
become similarly globalized. Since the 1980s, Ae. albopic-
tus has spread worldwide; it reached the United States in
1985, Brazil in 1986, Central America in 1988, and Africa
in 1992 (Figure 4) (10). In Europe, it was identified in
Albania in 1979 and in Italy in 1991, where it has become
established (10). In France, it was reported for the first
time in 1999 (35). It has also been introduced into several
other European countries, including Belgium, Bosnia and
Herzegovina, Croatia, Greece, the Netherlands, Serbia and
Montenegro, Slovenia, Spain, and Switzerland (19). In
2004, Ae. albopictus was identified in several areas of the
French Riviera, only 200 km from Marseilles, where 3 of
our viremic patients were hospitalized (36). Although Ae.
albopictus is active year-round in tropical (e.g., Central
America) and subtropical (e.g., Gulf Coast) latitudes, it
overwinters in its egg stage in the colder latitudes of the
Northern Hemisphere. Therefore, risk for CHIKV spread
is probably absent during colder months in Europe.
However, in Italy, Ae. albopictus is active from February
through December, with a peak in August and September
(37). Whether ecologic conditions during the period of Ae.
albopictus activity in southern Europe and North America
support the development of a productive and persistent
viral cycle in local vector populations is unknown.
Furthermore, we do not know whether Ae. albopictus can
transmit vertically and thus transfer CHIKV to the next
generation (and the next season), as has been shown for
dengue virus (10). If viremic patients arrive in Italy,
France, or elsewhere in southern Europe during the sum-
mer, however, they could cause a European outbreak. The
risk may also exist in the Americas, where the Asian tiger
mosquito is prevalent.
Conclusion
In 1 year, >250,000 persons have been infected by a
new CHIKV variant on the Indian Ocean islands. Although
major differences in the fitness or virulence of CHIKV
may be associated with minor genetic differences, the most
likely explanation for this devastating outbreak is the pen-
etration into a region where the population is immunolog-
ically naive for CHIKV and where Ae. albopictus
proliferates. As this outbreak has spread, we believe this
type of outbreak could occur in other regions of the world
where competent vectors are prevalent. Because of high
viremia, the virus could also be directly transmitted to
healthcare workers. We must be prepared for the possibil-
ity of similar arboviral epidemics in such places.
Novel Chikungunya Virus Variant
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Figure 4. Estimated global dis-
tribution of Aedes albopictus
(areas enclosed in dotted
lines) and distribution of
chikungunya virus (stars) from
western Africa to southeastern
Asia, including the Indian
Ocean variant responsible for
the 2006 outbreak. The color
of the stars reflects the main
evolutionary lineages shown in
Figure 3. Ae. albopictus photo-
graph courtesy of James
Gathany, Centers for Disease
Control and Prevention.Acknowledgments
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